( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
20610
19175
19115
18278
Total Expenditure
19200
18460
20001
20502
PBIDT (Excl OI)
1410
715
-886
-2224
Other Income
2220
2414
2238
1887
Operating Profit
3630
3129
1352
-337
Exceptional Items
-1900
-167
-5221
NA
Depreciation
1370
1661
1503
1653
Profit Before Tax
310
1261
-5417
-2033
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
220
1221
-5443
-2083
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
220
1221
-5443
-2083
Minority Interest
0.00
NA
48
2
Shares of Associates
-10
4
-3
-2
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
210
1225
-5398
-2083
Equity Capital
640
638
638
637
Calculated EPS
0.32
1.92
-8.46
-3.27
Calculated EPS (Annualised)
1.31
7.68
-33.84
-13.08
No of Public Share Holdings
638663460
638102551
637845483
637382630
% of Public Share Holdings
100
100
100
100
PBIDTM% (Excl OI)
6.84
3.72
-4.63
-12.16
PBIDTM%
17.61
16.31
7.07
-1.84
PBDTM%
8.15
15.23
-20.47
-2.07
PBTM%
1.50
6.57
-28.33
-11.12
PATM%
1.06
6.36
-28.47
-11.39